Norflex and Obsessive rumination - a phase IV clinical study of FDA data
We study 1,862 people who take Norflex or have Obsessive rumination. No report of Obsessive rumination is found in people who take Norflex.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
No report is found.
What is Norflex?
Norflex has active ingredients of orphenadrine citrate. It is often used in muscle spasms. eHealthMe is studying from 1,758 Norflex users for its effectiveness, alternative drugs and more.
What is Obsessive Rumination?
Obsessive rumination (thinking and worry or rumination is an inability to gain control over recurrent, distressing thoughts, images) is found to be associated with 139 drugs and 96 conditions by eHealthMe.
Do you take Norflex and have Obsessive rumination?Check whether Obsessive rumination is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of Norflex:
- Norflex (1,758 reports)
Obsessive rumination treatments and more:
- Obsessive rumination (104 reports)
COVID vaccines that are related to Obsessive rumination:
- Obsessive rumination in Moderna COVID Vaccine
- Obsessive rumination in Pfizer BioNTech Covid Vaccine
- Obsessive rumination in Johnson and Johnson Covid Vaccine
How severe was Obsessive rumination and when was it recovered:
Expand to all the drugs that have ingredients of orphenadrine citrate:
All the drugs that are associated with Obsessive rumination:
All the conditions that are associated with Obsessive rumination:
How the study uses the data?
The study uses data from the FDA. It is based on orphenadrine citrate (the active ingredients of Norflex) and Norflex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.